Complete Lab Digitalization
Imagine a lab environment where data silos disappear and process development productivity triples. Most LIMS are focused on data capture, rather than dynamic procedure execution. With BIOVIA, Pfizer can move beyond the limitations of legacy LIMS to achieve a fully integrated, AI-driven R&D ecosystem.
While others offer fragmented software, BIOVIA’s ONE Lab solution provides a single, GxP-ready environment that bridges the gap between R&D and Manufacturing.
Don’t rely on multiple vendors and systems to tackle your lab digitalization challenges. BIOVIA integrates task-oriented sample management, procedure execution, inventory and equipment management on a single platform, with a common data model—streamlining workflows and accelerating process development.
We understand the nuances of biotherapeutics and small-molecule development. Our platform is designed to:
Eliminate Data Silos
Connect disparate workflows into one cohesive digital thread
Ensure Compliance
Maintain a rigorous, audit-ready environment without sacrificing agility
Accelerate Tech Transfer
Standardize process definitions to move molecules from the lab to the plant faster than ever before
Data is only as good as its structure. Our core strategy integrates Scientific AI across the pharmaceutical lifecycle. By ensuring your data is structured and contextualized at the point of entry, we help boost R&D speed and efficiency, turning months of manual data aggregation into seconds of automated insight.
Traditional LIMS were built for yesterday’s data challenges. Download our e-book for a strategic roadmap for Pfizer to transition to a completely digital lab experience that prioritizes process development, productivity and Scientific AI readiness.